EGFR and neoplasm: Tyrosine kinase activity of epidermal growth factor (EGFR) promotes tumor cell proliferation, cell survival, angiogenesis, invasion, and metastasis, and its specific inhibition by gefitinib, a synthetic anilinoquinazoline, has been demonstrated (32).